Market Currents
Perrigo (PRGO) is up 1.7% after announcing it has filed for a new drug application with the FDA...
-
Wednesday, November 2, 2011, 8:48 AM ETPerrigo (PRGO) is up 1.7% after announcing it has filed for a new drug application with the FDA for its Androgel testosterone gel, which currently generates $900M in annual worldwide sales. However, Perrigo adds that Abbott (ABT) has filed a patent infringement suit against it over the product.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
